CrossRef Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic DysfunctionAssociated Steatotic Liver Disease JeeFu Huang, ChiYi Chen, MingJong Bair, TzuChun Lin, MingLun Yeh, PeiChien Tsai, YuJu Wei, ChihWen Wang, PoChen Liang, MingYen Hsieh, MeiHsuan Lee, ChiaYen Dai, ChungFeng Huang, MingLung Yu, WanLong Chuang The Kaohsiung Journal of Medical Sciences .2026;[Epub] CrossRef A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo Journal of Hepatology .2025

The contributions of the NIH authors were made as part of their official duties as NIH federal employees, are in compliance with agency policy requirements, and are considered works of the United States Government
Early real-world evidence studies have already begun to confirm a consistent reduction of HHF with SGLT2 inhibitors, and ongoing studies are set to provide more comprehensive insights [73]
The same docking protocol was applied to Ongga ( Strychnos lucida R.Br.), where ten previously reported phytoconstituents were screened against several antidiabetic targets, including human aldose reductase (2HV5), human maltase-glucoamylase (2QMJ), PPAR-gamma (3TY0), pancreatic beta-cell SUR1 (6PZA), and human DPP-IV (3BJM)
Injections, however, deliver a potent, concentrated dose directly into the subdermal tissue where it can immediately signal your cells to begin the repair process, making it a much more effective approach for significant results